unknown
Stage
2
Investors
About
Cadence Neuroscience is developing a personalized neuromodulation system to treat drug-resistant epilepsy; the system is designed to detect specific brain signals and deliver targeted electrical stimulation to modify neural circuit activity. The company and technology were incubated at Mayo Clinic.
Explore Cadence Neuroscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.